Zobrazeno 1 - 4
of 4
pro vyhledávání: '"María Begoña Cachón-González"'
Autor:
Eva Zaccariotto, María Begoña Cachón-González, Bing Wang, Sungtaek Lim, Bradford Hirth, Hyejung Park, Malika Fezoui, S.Pablo Sardi, Paul Mason, Robert H. Barker, Jr, Timothy M. Cox
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 149, Iss , Pp 112808- (2022)
Krabbe disease is a rare, inherited neurodegenerative disease due to impaired lysosomal β-galactosylceramidase (GALC) activity and formation of neurotoxic β-galactosylsphingosine (‘psychosine’). We investigated substrate reduction therapy with
Externí odkaz:
https://doaj.org/article/77cf7efe886d460196850a21fcc8a250
Autor:
Beatriz Castejón-Vega, Alejandro Rubio, Antonio J. Pérez-Pulido, José L. Quiles, Jon D. Lane, Beatriz Fernández-Domínguez, María Begoña Cachón-González, Carmen Martín-Ruiz, Alberto Sanz, Timothy M. Cox, Elísabet Alcocer-Gómez, Mario D. Cordero
Publikováno v:
Cells, Vol 10, Iss 11, p 3122 (2021)
Aims: Tay–Sachs and Sandhoff diseases (GM2 gangliosidosis) are autosomal recessive disorders of lysosomal function that cause progressive neurodegeneration in infants and young children. Impaired hydrolysis catalysed by β-hexosaminidase A (HexA) l
Externí odkaz:
https://doaj.org/article/f52039e69fcc4dfe90d6e42e02924715
Autor:
Castejón-Vega, Beatriz1 (AUTHOR) Beatriz.CastejonVega@glasgow.ac.uk, Rubio, Alejandro2 (AUTHOR) arubval@upo.es, Pérez-Pulido, Antonio J.2 (AUTHOR) ajpulido@upo.es, Quiles, José L.3 (AUTHOR) jlquiles@ugr.es, Lane, Jon D.4 (AUTHOR) Jon.Lane@bristol.ac.uk, Fernández-Domínguez, Beatriz5 (AUTHOR) beatriz@actays.org, Cachón-González, María Begoña6 (AUTHOR) mcb23@medschl.cam.ac.uk, Martín-Ruiz, Carmen7 (AUTHOR) carmen.martin-ruiz@newcastle.ac.uk, Sanz, Alberto8 (AUTHOR) Alberto.SanzMontero@glasgow.ac.uk, Cox, Timothy M.6 (AUTHOR) tmc12@medschl.cam.ac.uk, Alcocer-Gómez, Elísabet9 (AUTHOR) ealcocer1@us.es, Cordero, Mario D.10,11 (AUTHOR) mario.cordero@inibica.es
Publikováno v:
Cells (2073-4409). Nov2021, Vol. 10 Issue 11, p3122. 1p.
Drug Delivery Systems for Metabolic Disorders presents the most recent developments on the targeted delivery of drugs to deal with metabolic disorders in a safe, compliant and continuous way. The book covers recent developments in advanced drug deliv
